Ravgen and Illumina Settle Patent Lawsuit Over Genetic Testing

Gene-sequencing giant Illumina Inc has settled a patent lawsuit brought by Maryland biotech company Ravgen Inc, which accused Illumina’s genetic tests of infringing its patents.

The companies told a Delaware federal court Friday that they settled the case. Ravgen attorney John Desmarais on Monday called it “a mutually satisfactory settlement between the two parties” but did not disclose terms of the deal, which are confidential.

San Diego-based Illumina declined to comment on Monday.

Ravgen has filed a series of lawsuits against companies including Illumina, Natera and Roche’s Ariosa Diagnostics over DNA-testing technology. It won a $272 million jury verdict against Labcorp in Texas last September and settled a lawsuit against Quest Diagnostics shortly before a trial was set to begin in October.

Read the source article at wtvbam.com